Sanofi vs Stryker
Sanofi (SNY), health care, and Stryker (SYK), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Stryker is worth $120.1B on the stock market and Sanofi $115B: Stryker is valued at 4% more. Sanofi trades at 23.8 times earnings and Stryker at 33.6; operating margins in their latest fiscal years were 14.5% and 19.5%. Over the past year Sanofi's share price has moved -4.48% and Stryker's -13.6%.
Key facts
- Sanofi market value
- $115B
- Stryker market value
- $120.1B
- Sanofi P/E
- 23.8
- Stryker P/E
- 33.6
- Sanofi revenue
- $48.4BFY to 2025-12-31
- Stryker revenue
- $25.1BFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | Sanofi | Stryker |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $115Blower | $120.1Bhigher |
| Revenue | $48.4Bhigher | $25.1Blower |
| Earnings | $8.7Bhigher | $3.2Blower |
| Employees | 74,846higher | 56,000lower |
| Total assets | $140.7Bhigher | $47.8Blower |
| Valuation | ||
| P/E | 23.8lower | 33.6higher |
| P/S | 2.4lower | 4.8higher |
| P/B | — | 5.1 |
| Dividend yield | — | 1.13% |
| Profitability | ||
| Operating margin | 14.5%lower | 19.5%higher |
| Balance sheet | ||
| Net assets | $79.2Bhigher | $22.4Blower |
| Total liabilities | $61.1Bhigher | $25.4Blower |
| Total debt | $20.8Bhigher | $15.9Blower |
| Cash on hand | $8.5Bhigher | $4Blower |
| Price change | ||
| Today | -1.05%lower | +1.53%higher |
| 1 year | -4.48%higher | -13.6%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
Sanofi only (7)
- Charles Brandes (founder)1.2%
- Louis Bacon0.5%
- Sarah Ketterer0.4%
- Dodge & Cox team0.3%
- Ken Fisher0.1%
- Lee Ainslie<0.1%
- Richard Pzena<0.1%
Stryker only (8)
- Terry Smith5.7%
- Jensen team3.1%
- Diamond Hill team1.5%
- Jeremy Grantham (co-founder)0.8%
- Doug Silverman0.7%
- Steve Cohen0.2%
- Primecap team0.1%
- Mairs & Power team<0.1%
Percentages are each holding's share of that investor's reported portfolio. Who owns SNY · Who owns SYK
More on Sanofi
Further comparisons
Sanofi against its closest peers
Stryker against its closest peers
Learn
Questions and answers
Which is bigger, Sanofi or Stryker?
By market value, Stryker is the larger: $120.1B against $115B for Sanofi. By revenue in its latest fiscal year, Sanofi is the larger: $48.4B against $25.1B for Stryker.
Which has the higher P/E ratio?
Stryker: 33.6, against 23.8 for Sanofi. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
Stryker: 19.5%, against 14.5% for Sanofi. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has more debt?
Sanofi: $20.8B, against $15.9B for Stryker. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Sanofi and Stryker?
None of the tracked superinvestors holds both in their latest 13F filing. 7 hold Sanofi and 8 hold Stryker.
Cite this page
Funkfolio, “Sanofi vs Stryker”, data as of 17 November 2026. https://funkfolio.com/compare/sny-vs-syk
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.